CliffBio
small molecule

SILODOSIN

SILODOSIN

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameSILODOSIN
Active ingredientSILODOSIN
Strength8MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2018
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.